After conducting meta‐analysis, the results showed that the expression level of TP53 mutation was significantly associated with increased diagnosis efficiency of the occurrence of Ta stage bladder cancer(OR = 3.75; 95%CI, 2.50–5.63; p < 0.00001). The gene discussed is TP53; the disease is urinary bladder carcinoma.